The study aimed to demonstrate the expression of hypoxia-inducible factor (HIF-1α) in soft tissue mesenchymal tumours (fibroma and fibrosarcoma) in dogs. An attempt was made to correlate the obtained results with density of blood vessels (expression of von Willebrand Factor, vWF), expression of Ki-67 proliferation antigen, and with intensity of apoptosis in studied tumours. The study was performed on paraffin sections of 15 fibromas and 40 fibrosarcomas sampled from 55 female dogs aged 6 to 16 years. Immunohistochemical staining against HIF-1α, vWF, and Ki-67 was performed. Apoptosis was detected with the use of TUNEL reaction. A significantly higher HIF-1α expression was noted in fibrosarcomas in comparison to fibromas (P < 0.0001). HIF-1α expression in fibromas manifested strong positive correlation with tumour vascularity (r = 0.67, P = 0.007). Moreover, HIF-1α expression in fibrosarcomas manifested a moderate positive correlation with tumour malignancy grade (r = 0.44, P = 0.004), tumour vascularity (r = 0.52, P < 0.001), Ki-67 antigen expression (r = 0.42; P = 0.007), and TUNELpositive cells (r = 0.37, P = 0.017). Expression of HIF-1α was detected in 86.7% of fibroma type tumours and in 100% of fibrosarcomas. In all studied tumours expression of HIF-1α manifested positive correlation with the density of blood vessels, and in fibrosarcomas it correlated also with malignancy grade, intensity of Ki-67 expression, and with intensity of apoptosis in tumour cells.
Introduction
Neoplastic cells cannot function at a distance from blood vessels exceeding 100 µm. In the preliminary period of proliferation they obtain oxygen and nutrients by diffusion (known as blood vessel-free phase of a tumour), providing them preliminary conditions for growth. This results from the development of a tumour of 1-2 mm in diameter (around 10 5 cells), which at this stage may persist in humans from a few months to a few years. The subsequent growth of the tumour requires the involvement of blood vessels (neoangiogenesis), the development of which, as a rule, cannot follow the progressive tumour growth. Therefore, hypoxia develops in the tumour environment, inducing apoptosis of neoplastic cells, i.e. through the pathway mediated by p53 protein, which also stimulates the process of angiogenesis (28) . Under conditions of hypoxia, the level of hypoxia-inducible growth factor (HIF-1α) increases also in neoplastic cells (2, 4, 30) .
HIF-1 is a heterodimer composed of two subunits, HIF-1α and HIF-1β. The HIF-1β is constitutively expressed independent of environmental oxygen concentration, while the HIF-1α is the key molecule regulating the cellular response to physiological and pathological hypoxia (11) . Turnover of the HIF-1α protein is regulated by ubiquitination and subsequent degradation in proteasomes (21) . It was found that under reduced oxygen concentration, the level of HIF-1α protein increases mainly through stabilisation of the protein. HIF-1 is responsible, i.e., for increased expression of glycolytic enzymes in the cells, and for activation of expression of gene encoding the vascular endothelial growth factor (VEGF), one of the factors, which stimulate angiogenesis (21) .
In general, HIF-1α activation increases the rate of tumour growth; however, there are some exceptions to this rule (17) . Embryonic cell tumours and transformed astrocytes implanted into the brain parenchyma are examples of experimental studies in which removal of HIF-1α increased tumour growth (5, 7) .
Other studies on the influence of HIF-1α expression on the level of apoptosis in neoplastic cells did not cause any unequivocal results. Although HIF-1α usually participates in adoptive responses under hypoxia to promote tumour cell survival, a role of HIF-1α in regulation of apoptosis has been also put under consideration (1, 7, 15) .
This study focused on determination of HIF-1α protein level in cells of soft tissue fibromas and fibrosarcomas in dogs. Moreover, a correlation between expression of HIF-1α and density of blood vessels quantified by expression of von Willebrand Factor (vWF) was investigated, and intensity of proliferation and apoptosis in neoplastic cells was examined. The study also aimed to investigate whether the mechanisms of angiogenetic process in canine sarcomas develop in the same manner as in human tumours of that type, which -in the future -might be used in various experimental models.
Material and Methods
Tissue samples, immunohistochemistry (IHC), and TUNEL method. Material for the study was sampled during the surgery from 55 female dogs of various breeds, aged 6 to 16 years. The tumours were verified by histopathological examination of the H&E sections and represented fibromas (15 cases) and fibrosarcomas (40 cases) located in the subcutaneous tissue.
Formalin-fixed and paraffin-embedded tissues were freshly cut (4 µm). The sections were mounted on Superfrost Plus slides (Menzel Gläser, Braunschweig Germany) and subsequently deparaffinised by boiling in antigen retrieval solution (pH 9 for HIF-1α and pH 6 for Ki-67; DakoCytomation, Denmark) using PT link rinse station (DakoCytomation). Then, the sections were incubated for 20 min at room temperature (RT) in Link48 automated staining platform (DakoCytomation) utilising murine primary monoclonal antibodies, diluted in the background reducing antibody diluent (DakoCytomation) and directed against HIF-1α (1:600; Novus Biologicals, USA), vWF (1:800; DakoCytomation), or Ki-67 (ready-to-use, DakoCytomation). The visualisation of the antigens was performed using EnVision FLEX (DakoCytomation), according to the manufacturer's instructions. All sections were counterstained with Mayer's haematoxylin. In all cases, controls were included, in which specific antibody was substituted by the primary negative control (DakoCytomation).
Apoptosis detection was performed utilising the ApopTag® peroxidase in situ apoptosis detection kit (Millipore, USA). Paraffin sections were dewaxed in xylene, rehydrated in alcohol, and rinsed in distilled water and 1x PBS, pH 7.4. Then, the sections were incubated in proteinase K (DakoCytomation) for 5 min at RT and rinsed in 1x PBS. Endogenous peroxidase was blocked by 5 min incubation in 3% H 2 O 2 /1x PBS. Subsequently, the sections were incubated with equilibration buffer for 10 min at RT, with subsequent incubation with TdT enzyme and reaction buffer at 37 C for 1 h. The reaction was stopped after 10 min incubation in the stop buffer and rinsed in 1x PBS. Then, antidioxygenin peroxidase-conjugated antibodies were applied for 30 min at RT. Following that, the sections were incubated for 10 min with diaminobenzidine (DAB; DakoCytomation) to visualise the TUNELpositive cell nuclei. Finally, the sections were counterstained with Mayer's haematoxylin and, after dehydration in alcohol, mounted in SUB-X mounting medium (both DakoCytomation).
Microscope examination allowed to divide the tumours into three groups of a variable malignancy grade on the basis of three parameters scored on a scale from 0 to 3 points: histological differentiation of the tumour, number of mitoses per 10 high power fields (under 400× magnification), and area of necrosis. The sum of the points enabled the distinction of three grades of malignancy (G) among the tumours: 2-3 pts -G1; 4-5 pts -G2; and 6-9 pts -G3 (29) .
Quantification of IHC reactions. Microphotographs of all studied tumours were subjected to computer-assisted image analysis via a computer coupled to an Olympus BX53 optical microscope (Olympus, Japan). The set had the potential to record images and to perform their digital analysis. The measurements were performed with the use of Cell A software (Olympus Soft Imaging Solution GmbH, Germany).
Expression of HIF-1α was evaluated using the modified semi-quantitative immunoreactive score (IRS) scale according to Remmele (Table 1) (19) . The method involves both proportion of positively stained cells and intensity of the colour reaction, while the final score is the product of the parameters (Table 1) , with values ranging from 0 to 12 points (no reaction -0 points; weak reaction -1-2 points, moderate reaction -3-4 points, and intense reaction -6-12 points). Microvessel density (MVD) of vWF-positive vessels was quantified under 200 × magnification in five intratumoural areas of the lesion and the final score was determined as a mean of the five quantified areas.
The Ki-67 antigen expression was appraised semiquantitatively, evaluating the proportion of positive cells 0%-5% -no reaction (0), 6%-25% -weak reaction (1), 26%-50% -moderate reaction (2), above 50% -intense reaction (3). TUNEL sections were scored under 400 × magnification in five areas, in which number of TUNEL-positive cells was counted. The final score represented the percentage of positive tumour cells to all tumour cells in the examined sections.
Statistical analysis. The results were subjected to statistical analysis using Prism 5.0 (GraphPad, La Jolla, USA) software, employing Mann-Whitney U test and Spearman's correlation analysis. Results were considered statistically significant when P < 0.05.
Results
Expression of HIF-1α protein was demonstrated in fibroma and fibrosarcoma cells located in the subcutaneous tissue. In all cases with positive reaction, the nuclear-cytoplasmic expression of HIF-1α was detected (Fig. 1) . Expression of HIF-1α was demonstrated in 86.7% of studied fibroma cases and in 100% fibrosarcomas. Moreover, evident differences in intensity of the protein expression were detected between the two types of tumours. In cases of fibroma, 80% of the tumours manifested expression of HIF-1α at the level 1, while expression at the level 2 was not noted in any of the studied cases, although at the level 3 was detected in 6.7% of the cases. In cases of fibrosarcoma, 25% of the tumours demonstrated expression of HIF-1α at the level 1, 37.5%, at 2 and 37.5% at 3. Thus, the obtained results demonstrated that expression of HIF-1α was always present in fibrosarcomas, but over 13% of fibroma cases lacked HIF-1α expression. Statistical analysis using U-Mann's-Whitney's test showed that expression of HIF-1α was significantly higher in fibrosarcomas than in fibromas (P < 0.0001) ( Fig. 2A) , and that the difference showed an increase in every grade of fibrosarcoma malignancy (Fig. 2B) . It was also demonstrated that differences in expression of HIF-1α protein between individual groups of histological malignancy were statistically significant only between G2 and G3 groups (P = 0.0018). Statistical analysis using Spearman's correlation test revealed a moderate positive correlation between the expression of HIF-1α and the tumour malignancy grade (G) (r = 0.44; P = 0.004) ( Table 2 and Table 3 ). 2 . HIF-1α expression in fibroma and fibrosarcoma (A) as related to grade of malignancy in the fibrosarcoma (B); ** P < 0.01; *** P < 0.001; **** P < 0.0001 Table 2 . Sperman's rank correlation coefficient r for parameters of tumours manifesting fibroma type ns -not significant; ** P < 0.01 Table 3 . Sperman's rank correlation coefficient r for parameters of tumours manifesting fibrosarcoma type ns -not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Analysis of microvessel density (MVD) using vWF demonstrated a difference in expression of the factor between fibrosarcomas and fibromas (P = 0.0056) in U-Mann's-Whitney's test (Fig. 3A) , but significant differences in expression of vWF between individual groups of fibrosarcoma histological malignancy were not observed (Fig. 3B) . Correlation between expressions of HIF-1α and vWF proteins was strong and positive, i.e. in fibrosarcomas Spearman's correlation coefficient reached r = 0.52 at P < 0.001, while in fibromas it was r = 0.67 at P = 0.007 (Table 2  and Table 3 ). Expression of Ki-67 proliferation antigen (Fig. 1) was the lowest in fibroma tumours and it differed significantly (P = 0.0009) from the expression noted in fibrosarcomas (Fig. 4A) , as well as in fibrosarcomas manifesting the highest grade (G3) of malignancy (P < 0.0001) (Fig. 4B) . The expression of Ki-67 was also markedly different between tumours of G2 and G3 grades of malignancy (P = 0.0005) (Fig. 4B) . In the group of fibrosarcomas, expression of the proliferation antigen, Ki-67, in Spearman's correlation test manifested a moderate positive correlation with expression of HIF-1α (r = 0.42; P = 0.007), while no (Table 2 and Table 3 ).
Fig. 4.
Ki-67 antigen expression in fibroma and fibrosarcoma (A) and as related to fibrosarcoma grade of malignancy (B) *** P < 0.001; **** P < 0.0001
Analysis of apoptosis intensity using TUNEL technique (Fig. 1) demonstrated that the number of apoptotic cells differed significantly between fibromas and fibrosarcomas (P < 0.0001) (Fig. 5A) , and between fibromas and fibrosarcomas with malignancy grade G2 and G3 (P < 0.0001) (Fig. 5B ). Significant differences in the number of apoptotic cells were demonstrated also between all individual malignancy grades of fibrosarcoma. Furthermore, correlation was analysed between apoptosis intensity and HIF-1α protein expression level. In the fibrosarcoma group Spearman's correlation test detected moderate positive correlation between the parameters (r = 0.37; P = 0.017), while no such significant correlation was detected in the fibroma group (Table 2 and Table 3 ). Within the fibrosarcoma group also a moderate positive correlation (r = 0.39; P = 0.013) was demonstrated between the intensity of apoptosis and expression of Ki-67 proliferative index, while in fibroma group this correlation was very strong (r = 0.71; P = 0.003). In the fibrosarcoma group intensity of apoptosis was highly correlated with the degree of tumour malignancy (r = 0.73; P < 0.0001). Additionally, fibromas occured in 3.3%, and fibrosarcomas in 6% of tumours within skin and subcutaneous tissues (8) .
Immunohistochemical studies demonstrated increased HIF-1α expression in various human neoplastic tumours, resulting from hypoxia in tumour environment and from genetic disturbances (27) . Among human tumours of mesenchymal origin, an elevated level of HIF-1α protein was detected, among others, in tumours of malignant fibrous histiocytoma (22) , synovial sarcoma (22) , leiomyosarcoma (22) , malignant peripheral nerve sheath tumours (22), Kaposi's sarcoma (14) , and fibrosarcoma (25) types.
Our study revealed a significant difference in HIF-1α expression between fibroma and fibrosarcoma, which may be helpful in distinction between benign and malignant canine tumours of mesenchymal origin. The highest expression of HIF-1α in the group with the highest grade of malignancy suggests a certain relation between the expression levels of this protein with the grade of malignancy of the tumour, and indicates a pronounced hypoxia in tumours of the type. In our studies expression of HIF-1α reached the highest level in the group of tumours with the highest grade of malignancy (G3), which probably led to the most pronounced expression of VEGF, and which, according to Francis et al. (9) , is connected with the highest risk of metastases.
HIF-1α overexpression in humans was shown to manifest positive correlation with expression of VEGF and with MVD in most tumours of the central nervous system (2), cervical cancer (4), epithelial ovarian tumours (3), ductal mammary carcinoma (6), colon adenocarcinoma (13), endometrial adenocarcinoma (18), pancreatic ductal adenocarcinoma (26), small-cell pulmonary carcinoma (23) , colon cancer (12, 24) , gastric and gastro-oesophageal adenocarcinomas, and oesophageal cancer (16) . The relationship seems to be of significance since not only elevated HIF-1α expression is linked to increased VEGF levels, but absence of HIF-1α expression in several cases resulted in a decreased VEGF level and, thus inhibited process of neoangiogenesis (20) . The studies conducted have demonstrated a positive correlation between expressions of HIF-1α and MVD in both fibroma and fibrosarcoma tumours. Therefore, non-malignant and malignant tumours seem to use a similar mechanism to avoid hypoxia, but they take advantage of the mechanism to a different extent. Interestingly, in cases of fibrosarcoma the higher expression of HIF-1α in the group with the highest grade of malignancy (G3) was not accompanied by an increase in the number of blood vessels. Most probably, this resulted from attainment of a certain maximum development of microvessels, which could not be surpassed due to an exceedingly fast growth of tumours.
Shintani et al. (22) in their studies on human softtissue sarcomas failed to demonstrate any relationship between the expression of HIF-1a and Ki-67 antigen. Our results demonstrated a moderate correlation between the above mentioned parameters in fibrosarcoma type tumours, and an absence of such correlation in the case of fibroma. Expression of both HIF-1α and Ki-67 has been significantly higher in fibrosarcomas of G3 than in those of G2 malignancy grade or in fibromas. Thus, a pronounced expression of HIF-1α in canine soft tissue fibrosarcomas represents a good marker of proliferative lesions. Most probably, the increased expression of HIF-1α stimulates tumour blood supply, facilitating nutrition and gas exchange in neoplastic cells, promoting this way their increased proliferation.
HIF-1α usually promotes tumour cell survival under hypoxia, although pro-apoptotic function of this protein was also suggested (7, 10, 15) . Considering the significantly higher expression of HIF-1α, and the higher number of TUNEL-positive cells in fibrosarcoma than in fibroma, our results confirmed the hypothesis that in the case of hypoxia developing in particular in malignant tumours, intensity of apoptosis depends on the expression of HIF-1α. The moderate correlation between the above mentioned parameters in the case of fibrosarcomas and the absence of such correlation in the case of fibromas suggests the involvement of additional apoptosis-controlling pathways, which cooperate with the action of HIF-1α in dogs.
Summing up, it should be noted that in the examined cases of canine tumours of mesenchymal origin, expression of HIF-1α was significantly higher in malignant tumours (fibrosarcomas) than in nonmalignant tumours (fibromas), and that it had an influence on their vascular supply.
